Maki is an early-stage industry-agnostic global fund from Finland. Their main geographical focus is developed Europe, especially Northern Europe.
They look at all kinds of companies, especially those with scientific advances and customer understanding. This includes strong deep tech and/or brand-driven cases.
They invest also in very early stage, if the team and case is especially promising.
Voima Ventures funds research-based deep technology. Pharmaceutical technology is interesting, drug development is not. Content (e.g. game) development is also not interesting, but related technology is.
They collaborate closely with universities and innovation service providers, for example universities’ internal innovation services.
They prefer to co-invest or lead. They seek a board seat when investing. In early stages they prefer to be actively involved in the management of the company.